- Home
- PTCT vs VNT Comparison
PTCT vs VNT Comparison
Compare PTCT & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTCT | VNT |
|---|---|---|
| Founded | 1998 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.9B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTCT | VNT |
|---|---|---|
| Price | $69.35 | $41.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 9 |
| Target Price | ★ $76.28 | $47.56 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 02-19-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ 0.36 |
| EPS | ★ 8.94 | 2.76 |
| Revenue | $1,779,150,000.00 | ★ $3,075,600,000.00 |
| Revenue This Year | $132.16 | $1.80 |
| Revenue Next Year | N/A | $5.37 |
| P/E Ratio | ★ $7.77 | $15.14 |
| Revenue Growth | ★ 97.54 | 3.24 |
| 52 Week Low | $35.95 | $27.22 |
| 52 Week High | $87.50 | $48.20 |
Technical Indicators
Market Signals| Indicator | PTCT | VNT |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 61.64 |
| Support Level | $69.75 | $38.86 |
| Resistance Level | $76.99 | $48.20 |
| Average True Range (ATR) | 2.60 | 1.94 |
| MACD | -0.44 | 0.34 |
| Stochastic Oscillator | 13.85 | 47.56 |
Price Performance
Historical ComparisonAbout PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About VNT Vontier Corporation
Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.